Acorn Capital Advisors as of Sept. 30, 2025
Portfolio Holdings for Acorn Capital Advisors
Acorn Capital Advisors holds 20 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cg Oncology (CGON) | 23.1 | $46M | 1.1M | 40.28 | |
| Urogen Pharma (URGN) | 12.8 | $25M | 1.3M | 19.95 | |
| Puma Biotechnology (PBYI) | 11.1 | $22M | 4.1M | 5.31 | |
| Trevi Therapeutics (TRVI) | 10.0 | $20M | 2.1M | 9.15 | |
| Terns Pharmaceuticals (TERN) | 7.5 | $15M | 2.0M | 7.51 | |
| Candel Therapeutics (CADL) | 6.7 | $13M | 2.6M | 5.10 | |
| Bicara Therapeutics (BCAX) | 5.2 | $10M | 643k | 15.79 | |
| Onkure Therapeutics Class A Com (OKUR) | 4.0 | $7.8M | 2.8M | 2.75 | |
| Protara Therapeutics Com Stk (TARA) | 3.9 | $7.6M | 1.8M | 4.35 | |
| Verastem (VSTM) | 3.5 | $6.9M | 780k | 8.83 | |
| Cybin Com New (CYBN) | 2.2 | $4.3M | 734k | 5.87 | |
| Cardiff Oncology (CRDF) | 2.1 | $4.0M | 2.0M | 2.06 | |
| Aura Biosciences (AURA) | 1.9 | $3.7M | 596k | 6.18 | |
| Bioatla (BCAB) | 1.7 | $3.3M | 4.8M | 0.69 | |
| Jasper Therapeuritc (JSPR) | 1.7 | $3.3M | 1.4M | 2.38 | |
| Aadi Bioscience (WHWK) | 1.1 | $2.2M | 1.1M | 1.90 | |
| Q32 Bio (QTTB) | 0.8 | $1.6M | 803k | 1.98 | |
| X4 Pharmaceuticals | 0.5 | $935k | 273k | 3.42 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.4 | $734k | 405k | 1.81 | |
| Vyne Therapeutics (VYNE) | 0.1 | $199k | 587k | 0.34 |
